The ubiquitin-proteasome system and cardiovascular disease

Progress in Molecular Biology and Translational Science

Volumn 109, Issue , 2012, Pages 295-346

  Powell, Saul R ^a   Herrmann, Joerg ^b   Lerman, Amir ^b   Patterson, Cam ^c   Wang, Xuejun ^d  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Atherosclerosis; Cardiomyopathy; Heart; Heart failure; Myocardial ischemia; Preconditioning; Protein quality control; Ubiquitin protein ligases; Ubiquitin proteasome system; Vascular

Indexed keywords

EID: 84862741327     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397863-9.00009-2     Document Type: Chapter

References (231)

1. A.V. Gomes, C. Zong, R.D. Edmondson, B.T. Berhane, G.W. Wang, and S. Le The murine cardiac 26S proteasome: an organelle awaiting exploration Ann N Y Acad Sci 1047 2005 197 207 (Pubitemid 41123840)
2. A.V. Gomes, C. Zong, R.D. Edmondson, X. Li, E. Stefani, and J. Zhang Mapping the murine cardiac 26S proteasome complexes Circ Res 99 2006 362 371 (Pubitemid 44253692)
3. O. Drews, R. Wildgruber, C. Zong, U. Sukop, M. Nissum, and G. Weber Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities Mol Cell Proteomics 6 2007 2021 2031 (Pubitemid 350201875)
4. A.V. Gomes, G.W. Young, Y. Wang, C. Zong, M. Eghbali, and O. Drews Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues Mol Cell Proteomics 8 2009 302 315
5. G.W. Young, Y. Wang, and P. Ping Understanding proteasome assembly and regulation: importance to cardiovascular medicine Trends Cardiovasc Med 18 2008 93 98 (Pubitemid 351626605)
6. S.R. Powell The cardiac 26S proteasome. Regulating the regulator Circ Res 99 2006 342 345 (Pubitemid 44253687)
7. D. Wang, C. Zong, M.C. Koag, Y. Wang, O. Drews, and C. Fang Proteome dynamics and proteome function of cardiac 19S proteasomes Mol Cell Proteomics 10 2011 M110
8. F. Zhang, K. Su, X. Yang, D.B. Bowe, A.J. Paterson, and J.E. Kudlow O-GlcNAc modification is an endogenous inhibitor of the proteasome Cell 115 2003 715 725 (Pubitemid 38030300)
9. F. Zhang, Y. Hu, P. Huang, C.A. Toleman, A.J. Paterson, and J.E. Kudlow Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6 J Biol Chem 282 2007 22460 22471 (Pubitemid 47267329)
10. O. Drews, O. Tsukamoto, D. Liem, J. Streicher, Y. Wang, and P. Ping Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy Circ Res 107 2010 1094 1101
11. H. Lu, C. Zong, Y. Wang, G.W. Young, N. Deng, and P. Souda Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach Mol Cell Proteomics 7 2008 2073 2089
12. C. Zong, G.W. Young, Y. Wang, H. Lu, N. Deng, and O. Drews Two-dimensional electrophoresis-based characterization of post-translational modifications of mammalian 20S proteasome complexes Proteomics 8 2008 5025 5037
13. C. Zong, A.V. Gomes, O. Drews, X. Li, G.W. Young, and B. Berhane Regulation of murine cardiac 20S proteasomes: role of associating partners Circ Res 99 2006 372 380 (Pubitemid 44253693)
14. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
15. C. Weber, A. Zernecke, and P. Libby The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models Nat Rev Immunol 8 2008 802 815
16. V. Stangl, M. Lorenz, S. Meiners, A. Ludwig, C. Bartsch, and M. Moobed Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway FASEB J 18 2004 272 279 (Pubitemid 38186246)
17. Q. Wei, and Y. Xia Proteasome inhibition down-regulates endothelial nitric-oxide synthase phosphorylation and function J Biol Chem 281 2006 21652 21659 (Pubitemid 44181868)
18. J. Herrmann, A.M. Saguner, D. Versari, T.E. Peterson, A. Chade, and M. Olson Chronic proteasome inhibition contributes to coronary atherosclerosis Circ Res 101 2007 865 874 (Pubitemid 350287173)
19. T. Xia, C. Dimitropoulou, J. Zeng, G.N. Antonova, C. Snead, and R.C. Venema Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase Am J Physiol Cell Physiol 293 2007 H3080 H3087
20. J. Xu, Y. Wu, P. Song, M. Zhang, S. Wang, and M.H. Zou Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus Circulation 116 2007 944 953 (Pubitemid 47300919)
21. J. Whitsett, M.J. Picklo Sr., and J. Vasquez-Vivar 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation Arterioscler Thromb Vasc Biol 27 2007 2340 2347 (Pubitemid 350203948)
22. U. Forstermann, and T. Munzel Endothelial nitric oxide synthase in vascular disease: from marvel to menace Circulation 113 2006 1708 1714
23. W. Li, and A.N. Kong Molecular mechanisms of Nrf2-mediated antioxidant response Mol Carcinog 48 2009 91 104
24. H.M. Park, J.A. Kim, and M.K. Kwak Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome Arch Pharm Res 32 2009 109 115
25. H. Dreger, K. Westphal, N. Wilck, G. Baumann, V. Stangl, and K. Stangl Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2 Cardiovasc Res 85 2010 395 403
26. S. Bieler, S. Meiners, V. Stangl, T. Pohl, and K. Stangl Comprehensive proteomic and transcriptomic analysis reveals early induction of a protective anti-oxidative stress response by low-dose proteasome inhibition Proteomics 9 2009 3257 3267
27. L. Farout, J. Mary, J. Vinh, L.I. Szweda, and B. Friguet Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes Arch Biochem Biophys 453 2006 135 142
28. O. Vieira, I. Escargueil-Blanc, G. Jurgens, C. Borner, L. Almeida, and R. Salvayre Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis FASEB J 14 2000 532 542 (Pubitemid 30143173)
29. S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49 2010 1603 1616
30. J. Herrmann, A. Ciechanover, L.O. Lerman, and A. Lerman The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended Cardiovasc Res 61 2004 11 21 (Pubitemid 38056676)
31. J. Herrmann, L.O. Lerman, D. Mukhopadhyay, C. Napoli, and A. Lerman Angiogenesis in atherogenesis Arterioscler Thromb Vasc Biol 26 2006 1948 1957 (Pubitemid 44253775)
32. T. Kietzmann, and A. Gorlach Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression Semin Cell Dev Biol 16 2005 474 486
33. E.L. Bradshaw, X.A. Li, T. Guerin, W.V. Everson, M.E. Wilson, and A.J. Bruce-Keller Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C Am J Physiol Cell Physiol 291 2006 C1271 C1278
34. M. Ogura, M. Ayaori, Y. Terao, T. Hisada, M. Iizuka, and S. Takiguchi Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo Arterioscler Thromb Vasc Biol 31 2011 1980 1987
35. Y. Masuda, H. Itabe, M. Odaki, K. Hama, Y. Fujimoto, and M. Mori ADRP/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells J Lipid Res 47 2006 87 98 (Pubitemid 43107452)
36. J. Kikuchi, Y. Furukawa, N. Kubo, A. Tokura, N. Hayashi, and M. Nakamura Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis Arterioscler Thromb Vasc Biol 20 2000 128 134 (Pubitemid 30048355)
37. P. Xie, Y. Fan, H. Zhang, Y. Zhang, M. She, and D. Gu CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation Mol Cell Biol 29 2009 2398 2408
38. S. Meiners, M. Laule, W. Rother, C. Guenther, I. Prauka, and P. Muschick Ubiquitin-proteasome pathway as a new target for the prevention of restenosis Circulation 105 2002 483 489 (Pubitemid 34141706)
39. K.G. Barringhaus, and M.E. Matsumura The proteasome inhibitor lactacystin attenuates growth and migration of vascular smooth muscle cells and limits the response to arterial injury Exp Clin Cardiol 12 2007 119 124 (Pubitemid 47526936)
40. W.Z. Ying, H.G. Zhang, and P.W. Sanders EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells J Am Soc Nephrol 18 2007 131 142 (Pubitemid 46053428)
41. M.R. Kapadia, J.W. Eng, Q. Jiang, D.A. Stoyanovsky, and M.R. Kibbe Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells Nitric Oxide 20 2009 279 288
42. K. Katsuyama, M. Shichiri, F. Marumo, and Y. Hirata NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha Arterioscler Thromb Vasc Biol 18 1998 1796 1802 (Pubitemid 28521071)
43. Y. Takami, H. Nakagami, R. Morishita, T. Katsuya, T.X. Cui, and T. Ichikawa Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation Arterioscler Thromb Vasc Biol 27 2007 2184 2190 (Pubitemid 350287248)
44. Y. Takami, H. Nakagami, R. Morishita, T. Katsuya, H. Hayashi, and M. Mori Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells Am J Pathol 172 2008 818 829 (Pubitemid 351354553)
45. M. Duwel, V. Welteke, A. Oeckinghaus, M. Baens, B. Kloo, and U. Ferch A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains J Immunol 182 2009 7718 7728
46. C.M. Weyand, B.R. Younge, and J.J. Goronzy T cells in arteritis and atherosclerosis Curr Opin Lipidol 19 2008 469 477
47. G.V. Shrikhande, S.T. Scali, C.G. da Silva, S.M. Damrauer, E. Csizmadia, and P. Putheti O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice PLoS One 5 2010 e14240
48. C. Lobry, T. Lopez, A. Israel, and R. Weil Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10 Proc Natl Acad Sci USA 104 2007 908 913 (Pubitemid 46154710)
49. C. Berges, H. Haberstock, D. Fuchs, M. Miltz, M. Sadeghi, and G. Opelz Proteasome inhibition suppresses essential immune functions of human CD4 + T cells Immunology 124 2008 234 246 (Pubitemid 351692904)
50. I. Kawahara, N. Kitagawa, K. Tsutsumi, I. Nagata, T. Hayashi, and T. Koji The expression of vascular dendritic cells in human atherosclerotic carotid plaques Hum Pathol 38 2007 1378 1385 (Pubitemid 47247481)
51. C. Naujokat, C. Berges, A. Hoh, H. Wieczorek, D. Fuchs, and J. Ovens Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells Immunology 120 2007 120 132 (Pubitemid 44950477)
52. C. Straube, R. Wehner, M. Wendisch, M. Bornhauser, M. Bachmann, and E.P. Rieber Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells Leukemia 21 2007 1464 1471 (Pubitemid 46965288)
53. A. Nencioni, A. Garuti, K. Schwarzenberg, G. Cirmena, G. Dal Bello, and I. Rocco Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells Eur J Immunol 36 2006 681 689
54. J.W. van der Heijden, R. Oerlemans, W.F. Lems, R.J. Scheper, B.A. Dijkmans, and G. Jansen The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients Clin Exp Rheumatol 27 2009 92 98
55. A.V. Vaseva, and U.M. Moll The mitochondrial p53 pathway Biochim Biophys Acta 1787 2009 414 420
56. P. Meier, D. Golshayan, E. Blanc, M. Pascual, and M. Burnier Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD J Am Soc Nephrol 20 2009 1368 1384
57. S. Taleb, A. Tedgui, and Z. Mallat Regulatory T-cell immunity and its relevance to atherosclerosis J Intern Med 263 2008 489 499 (Pubitemid 351533554)
58. Z. Yang, D. Gagarin, G. St Laurent III, N. Hammell, I. Toma, and C.A. Hu Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome Arterioscler Thromb Vasc Biol 29 2009 1213 1219
59. H.F. Yang-Yen Mcl-1: a highly regulated cell death and survival controller J Biomed Sci 13 2006 201 204
60. A. Cuconati, C. Mukherjee, D. Perez, and E. White DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells Genes Dev 17 2003 2922 2932 (Pubitemid 37523156)
61. W. Martinet, and G.R. De Meyer Autophagy in atherosclerosis Curr Atheroscler Rep 10 2008 216 223
62. W.X. Ding, H.M. Ni, W. Gao, T. Yoshimori, D.B. Stolz, and D. Ron Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability Am J Pathol 171 2007 513 524 (Pubitemid 47344684)
63. J.L. Van Herck, G.R. De Meyer, W. Martinet, H. Bult, C.J. Vrints, and A.G. Herman Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice Basic Res Cardiol 105 2010 39 50
64. D. Versari, J. Herrmann, M. Gossl, D. Mannheim, K. Sattler, and F.B. Meyer Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis Arterioscler Thromb Vasc Biol 26 2006 2132 2139 (Pubitemid 44253799)
65. J. Herrmann, S.M. Soares, L.O. Lerman, and A. Lerman Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease J Am Coll Cardiol 51 2008 2003 2010 (Pubitemid 351680522)
66. J. Herrmann, W.D. Edwards, D.R. Holmes Jr., K.L. Shogren, L.O. Lerman, and A. Ciechanover Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes J Am Coll Cardiol 40 2002 1919 1927 (Pubitemid 35425361)
67. R. Marfella, M. D'Amico, C. Di Filippo, A. Baldi, M. Siniscalchi, and F.C. Sasso Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment J Am Coll Cardiol 47 2006 2444 2455 (Pubitemid 43866361)
68. R. Marfella, M. D'Amico, K. Esposito, A. Baldi, C. Di Filippo, and M. Siniscalchi The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment Diabetes 55 2006 622 632 (Pubitemid 43343218)
69. R. Marfella, C. Di Filippo, A. Baldi, M. Siniscalchi, F.C. Sasso, and B. Crescenzi The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: role of glycemic control J Am Coll Cardiol 47 2006 2118 2120
70. R. Marfella, C. Di Filippo, M.T. Laieta, R. Vestini, M. Barbieri, and P. Sangiulo Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients J Gerontol A Biol Sci Med Sci 63 2008 200 203 (Pubitemid 351738453)
71. B. Friguet, A.L. Bulteau, N. Chondrogianni, M. Conconi, and I. Petropoulos Protein degradation by the proteasome and its implications in aging Ann N Y Acad Sci 908 2000 143 154 (Pubitemid 30462000)
72. A.L. Bulteau, L.I. Szweda, and B. Friguet Age-dependent declines in proteasome activity in the heart Arch Biochem Biophys 397 2002 298 304 (Pubitemid 34852295)
73. C. Tan, Y. Li, X. Tan, H. Pan, and W. Huang Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis Clin Chem Lab Med 44 2006 1218 1225 (Pubitemid 44580804)
74. B. Feng, Y. Zhang, J. Mu, Z. Ye, W. Zeng, and W. Qi Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia J Cardiovasc Pharmacol 55 2010 129 138
75. S. Meiners, A. Ludwig, V. Stangl, and K. Stangl Proteasome inhibitors: poisons and remedies Med Res Rev 28 2008 309 327 (Pubitemid 351281191)
76. J. Bao, K. Sato, M. Li, Y. Gao, R. Abid, and W. Aird PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation Am J Physiol Heart Circ Physiol 281 2001 H2612 H2618
77. Y. Gao, S. Lecker, M.J. Post, A.J. Hietaranta, J. Li, and R. Volk Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide J Clin Invest 106 2000 439 448 (Pubitemid 30655644)
78. H. Luss, W. Schmitz, and J. Neumann A proteasome inhibitor confers cardioprotection Cardiovasc Res 54 2002 140 151 (Pubitemid 34327944)
79. S.C. Bodine, E. Latres, S. Baumhueter, V.K. Lai, L. Nunez, and B.A. Clarke Identification of ubiquitin ligases required for skeletal muscle atrophy Science 294 2001 1704 1708 (Pubitemid 33104839)
80. M.D. Gomes, S.H. Lecker, R.T. Jagoe, A. Navon, and A.L. Goldberg Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy Proc Natl Acad Sci USA 98 2001 14440 14445 (Pubitemid 33121410)
81. Y.G. Ni, K. Berenji, N. Wang, M. Oh, N. Sachan, and A. Dey Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling Circulation 114 2006 1159 1168 (Pubitemid 44386480)
82. M. Sandri, C. Sandri, A. Gilbert, C. Skurk, E. Calabria, and A. Picard Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy Cell 117 2004 399 412 (Pubitemid 38534545)
83. J. Pye, F. Ardeshirpour, A. McCain, D.A. Bellinger, E. Merricks, and J. Adams Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury Am J Physiol Heart Circ Physiol 284 2003 H919 H926
84. B.J. Wilkins, Y.S. Dai, O.F. Bueno, S.A. Parsons, J. Xu, and D.M. Plank Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy Circ Res 94 2004 110 118 (Pubitemid 38064105)
85. H.H. Li, V. Kedar, C. Zhang, H. McDonough, R. Arya, and D.Z. Wang Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex J Clin Invest 114 2004 1058 1071 (Pubitemid 39578695)
86. W.E. Stansfield, N.C. Moss, M.S. Willis, R. Tang, and C.H. Selzman Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury Ann Thorac Surg 84 2007 120 125 (Pubitemid 46921115)
87. S.A. Johnson, and T. Hunter Kinomics: methods for deciphering the kinome Nat Methods 2 2005 17 25 (Pubitemid 41131053)
88. H.H. Li, M.S. Willis, P. Lockyer, N. Miller, H. McDonough, and D.J. Glass Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins J Clin Invest 117 2007 3211 3223 (Pubitemid 350096979)
89. P.S. Coleman, M.S. Parmacek, M. Lesch, and A.M. Samarel Protein synthesis and degradation during regression of thyroxine-induced cardiac hypertrophy J Mol Cell Cardiol 21 1989 911 925 (Pubitemid 19260815)
90. K.D. Wilkinson, K.H. Ventii, K.L. Friedrich, and J.E. Mullally The ubiquitin signal: assembly, recognition and termination. Symposium on ubiquitin and signaling EMBO Rep 6 2005 815 820 (Pubitemid 43108669)
91. T. Centner, J. Yano, E. Kimura, A.S. McElhinny, K. Pelin, and C.C. Witt Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain J Mol Biol 306 2001 717 726 (Pubitemid 33027694)
92. A.S. McElhinny, K. Kakinuma, H. Sorimachi, S. Labeit, and C.C. Gregorio Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 J Cell Biol 157 2002 125 136 (Pubitemid 34847835)
93. J.A. Spencer, S. Eliazer, R.L. Ilaria Jr., J.A. Richardson, and E.N. Olson Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein J Cell Biol 150 2000 771 784 (Pubitemid 30663414)
94. V. Adams, A. Linke, U. Wisloff, C. Doring, S. Erbs, and N. Krankel Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility Cardiovasc Res 73 2007 120 129 (Pubitemid 44937197)
95. P. Razeghi, K.K. Baskin, S. Sharma, M.E. Young, S. Stepkowski, and M.F. Essop Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart Biochem Biophys Res Commun 342 2006 361 364 (Pubitemid 43289002)
96. M.S. Parmacek, N.M. Magid, M. Lesch, R.S. Decker, and A.M. Samarel Cardiac protein synthesis and degradation during thyroxine-induced left ventricular hypertrophy Am J Physiol 251 1986 C727 C736
97. M.S. Willis, C. Ike, L. Li, D.Z. Wang, D.J. Glass, and C. Patterson Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo Circ Res 100 2007 456 459 (Pubitemid 46673255)
98. S. Cohen, J.J. Brault, S.P. Gygi, D.J. Glass, D.M. Valenzuela, and C. Gartner During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation J Cell Biol 185 2009 1083 1095
99. N. Frey, and E.N. Olson Cardiac hypertrophy: the good, the bad, and the ugly Annu Rev Physiol 65 2003 45 79 (Pubitemid 38249147)
100. R. Arya, V. Kedar, J.R. Hwang, H. McDonough, H.H. Li, and J. Taylor Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy J Cell Biol 167 2004 1147 1159 (Pubitemid 40066629)
101. M.S. Willis, M. Rojas, L. Li, C.H. Selzman, R.H. Tang, and W.E. Stansfield Muscle ring finger 1 mediates cardiac atrophy in vivo Am J Physiol Heart Circ Physiol 296 2009 H997 H1006
102. C. Zhang, Z. Xu, X.R. He, L.H. Michael, and C. Patterson CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice Am J Physiol Heart Circ Physiol 288 2005 H2836 H2842
103. M. Hoshijima Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures Am J Physiol Heart Circ Physiol 290 2006 H1313 H1325
104. C.C. Gregorio, C.N. Perry, and A.S. McElhinny Functional properties of the titin/connectin-associated proteins, the muscle-specific RING finger proteins (MURFs), in striated muscle J Muscle Res Cell Motil 26 2005 389 400
105. M. Mrosek, D. Labeit, S. Witt, H. Heerklotz, E. von Castelmur, and S. Labeit Molecular determinants for the recruitment of the ubiquitin-ligase MuRF-1 onto M-line titin FASEB J 21 2007 1383 1392 (Pubitemid 46684841)
106. R.S. Foo, L.K. Chan, R.N. Kitsis, and M.R. Bennett Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2 J Biol Chem 282 2007 5529 5535 (Pubitemid 47093728)
107. S. Xiong, C.S. Van Pelt, A.C. Elizondo-Fraire, B. Fernandez-Garcia, and G. Lozano Loss of Mdm4 results in p53-dependent dilated cardiomyopathy Circulation 115 2007 2925 2930 (Pubitemid 46912095)
108. J. Fielitz, E. van Rooij, J.A. Spencer, J.M. Shelton, S. Latif, and R. van der Nagel Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction Proc Natl Acad Sci USA 104 2007 4377 4382 (Pubitemid 47186234)
109. J. Fielitz, M.S. Kim, J.M. Shelton, S. Latif, J.A. Spencer, and D.J. Glass Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3 J Clin Invest 117 2007 2486 2495 (Pubitemid 47494350)
110. B.J. Maron Triggers for sudden cardiac death in the athlete Cardiol Clin 14 1996 195 210 (Pubitemid 26153993)
111. G. Bonne, L. Carrier, P. Richard, B. Hainque, and K. Schwartz Familial hypertrophic cardiomyopathy: from mutations to functional defects Circ Res 83 1998 580 593 (Pubitemid 28427741)
112. P. Richard, P. Charron, L. Carrier, C. Ledeuil, T. Cheav, and C. Pichereau Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2003 2227 2232 (Pubitemid 36547217)
113. X. Wang, and J. Robbins Heart failure and protein quality control Circ Res 99 2006 1315 1328 (Pubitemid 44949667)
114. J. Flavigny, P. Robert, J.C. Camelin, K. Schwartz, L. Carrier, and I. Berrebi-Bertrand Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathy Cardiovasc Res 60 2003 388 396 (Pubitemid 37412372)
115. A. Freiburg, and M. Gautel A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy Eur J Biochem 235 1996 317 323
116. M. Gruen, and M. Gautel Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C J Mol Biol 286 1999 933 949 (Pubitemid 29106227)
117. A. Sarikas, L. Carrier, C. Schenke, D. Doll, J. Flavigny, and K.S. Lindenberg Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants Cardiovasc Res 66 2005 33 44 (Pubitemid 40357866)
118. J.M. Squire, P.K. Luther, and C. Knupp Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain J Mol Biol 331 2003 713 724 (Pubitemid 36937155)
119. J.A. Moolman, S. Reith, K. Uhl, S. Bailey, M. Gautel, and B. Jeschke A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance Circulation 101 2000 1396 1402 (Pubitemid 30169861)
120. X. Wang, H. Su, and M.J. Ranek Protein quality control and degradation in cardiomyocytes J Mol Cell Cardiol 45 2008 11 27
121. T. Ravid, and M. Hochstrasser Diversity of degradation signals in the ubiquitin-proteasome system Nat Rev Mol Cell Biol 9 2008 679 690
122. J. Li, K.M. Horak, H. Su, A. Sanbe, J. Robbins, and X. Wang Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice J Clin Invest 121 2011 3689 3700
123. X. Wang, J. Li, H. Zheng, H. Su, and S.R. Powell Proteasome functional insufficiency in cardiac pathogenesis Am J Physiol Heart Circ Physiol 301 2011 H2207 H2219
124. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555 (Pubitemid 32493425)
125. X. Dong, J. Liu, H. Zheng, J.W. Glasford, W. Huang, and Q.H. Chen In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes Am J Physiol Heart Circ Physiol 287 2004 H1417 H1425
126. R.K.A. Kumarapeli, K.M. Horak, J.W. Glasford, J. Li, Q. Chen, and J. Liu A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin FASEB J 19 2005 2051 2053 (Pubitemid 41759762)
127. T. Gilon, O. Chomsky, and R.G. Kulka Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae EMBO J 17 1998 2759 2766 (Pubitemid 28227122)
128. T. Gilon, O. Chomsky, and R.G. Kulka Degradation signals recognized by the Ubc6p-Ubc7p ubiquitin-conjugating enzyme pair Mol Cell Biol 20 2000 7214 7219
129. T.A. Griffin, D. Nandi, M. Cruz, H.J. Fehling, L.V. Kaer, and J.J. Monaco Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits J Exp Med 187 1998 97 104 (Pubitemid 28044824)
130. U. Seifert, L.P. Bialy, F. Ebstein, D. Bech-Otschir, A. Voigt, and F. Schroter Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress Cell 142 2010 613 624
131. J. Li, S.R. Powell, and X. Wang Enhancement of proteasome function by PA28alpha; overexpression protects against oxidative stress FASEB J 25 2011 883 893
132. P.M. McLendon, and J. Robbins Desmin-related cardiomyopathy: an unfolding story Am J Physiol Heart Circ Physiol 301 2011 H1220 H1228
133. X. Wang, H. Osinska, R. Klevitsky, A.M. Gerdes, M. Nieman, and J. Lorenz Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice Circ Res 89 2001 84 91 (Pubitemid 34135496)
134. X. Wang, H. Osinska, G.W. Dorn, M. Nieman, J.N. Lorenz, and A.M. Gerdes Mouse model of desmin-related cardiomyopathy Circulation 103 2001 2402 2407 (Pubitemid 32448807)
135. A.M. Munoz-Marmol, G. Strasser, M. Isamat, P.A. Coulombe, Y. Yang, and X. Roca A dysfunctional desmin mutation in a patient with severe generalized myopathy Proc Natl Acad Sci USA 95 1998 11312 11317 (Pubitemid 28450125)
136. P. Vicart, A. Caron, P. Guicheney, Z. Li, M.C. Prevost, and A. Faure A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy Nat Genet 20 1998 92 95 (Pubitemid 28410353)
137. Q. Chen, J.B. Liu, K.M. Horak, H. Zheng, A.R. Kumarapeli, and J. Li Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake Circ Res 97 2005 1018 1026 (Pubitemid 41668915)
138. J. Liu, Q. Chen, W. Huang, K.M. Horak, H. Zheng, and R. Mestril Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts FASEB J 20 2006 362 364 (Pubitemid 46671172)
139. J. Liu, M. Tang, R. Mestril, and X. Wang Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes J Mol Cell Cardiol 40 2006 451 454
140. P. Tannous, H. Zhu, A. Nemchenko, J.M. Berry, J.L. Johnstone, and J.M. Shelton Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy Circulation 117 2008 3070 3078
141. N. Hedhli, and C. Depre Proteasome inhibitors and cardiac cell growth Cardiovasc Res 85 2010 321 329
142. M. Tang, J. Li, W. Huang, H. Su, Q. Liang, and Z. Tian Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts Cardiovasc Res 88 2010 424 433
143. D. Gianni, A. Li, G. Tesco, K.M. McKay, J. Moore, and K. Raygor Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy Circulation 121 2010 1216 1226
144. A. Sanbe, H. Osinska, J.E. Saffitz, C.G. Glabe, R. Kayed, and A. Maloyan Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis Proc Natl Acad Sci USA 101 2004 10132 10136 (Pubitemid 38891207)
145. A. Sanbe, J. Gulick, M.C. Hanks, Q. Liang, H. Osinska, and J. Robbins Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter Circ Res 92 2003 609 616 (Pubitemid 36417694)
146. A.J. Marian Hypertrophic cardiomyopathy: from genetics to treatment Eur J Clin Invest 40 2010 360 369
147. A. Maloyan, J. Gulick, C.G. Glabe, R. Kayed, and J. Robbins Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy Proc Natl Acad Sci USA 104 2007 5995 6000 (Pubitemid 47175647)
148. J.S. Pattison, A. Sanbe, A. Maloyan, H. Osinska, R. Klevitsky, and J. Robbins Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure Circulation 117 2008 2743 2751 (Pubitemid 351770455)
149. A. Sanbe, H. Osinska, C. Villa, J. Gulick, R. Klevitsky, and C.G. Glabe Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy Proc Natl Acad Sci USA 102 2005 13592 13597 (Pubitemid 41420893)
150. A.L. Goldberg On prions, proteasomes, and mad cows N Engl J Med 357 2007 1150 1152
151. M. Kristiansen, P. Deriziotis, D.E. Dimcheff, G.S. Jackson, H. Ovaa, and H. Naumann Disease-associated prion protein oligomers inhibit the 26S proteasome Mol Cell 26 2007 175 188 (Pubitemid 46617340)
152. E.J. Bennett, N.F. Bence, R. Jayakumar, and R.R. Kopito Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation Mol Cell 17 2005 351 365 (Pubitemid 40193307)
153. A. Sanbe, J. Yamauchi, Y. Miyamoto, Y. Fujiwara, M. Murabe, and A. Tanoue Interruption of CryAB-amyloid oligomer formation by HSP22 J Biol Chem 282 2007 555 563 (Pubitemid 47076667)
154. A. Maloyan, A. Sanbe, H. Osinska, M. Westfall, D. Robinson, and K. Imahashi Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy Circulation 112 2005 3451 3461 (Pubitemid 43739561)
155. O. Tsukamoto, T. Minamino, K. Okada, Y. Shintani, S. Takashima, and H. Kato Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice Biochem Biophys Res Commun 340 2006 1125 1133 (Pubitemid 43083395)
156. J.D. Molkentin, J.R. Lu, C.L. Antos, B. Markham, J. Richardson, and J. Robbins A calcineurin-dependent transcriptional pathway for cardiac hypertrophy Cell 93 1998 215 228 (Pubitemid 28180855)
157. A.R. Kumarapeli, H. Su, W. Huang, M. Tang, H. Zheng, and K.M. Horak Alpha B-crystallin suppresses pressure overload cardiac hypertrophy Circ Res 103 2008 1473 1482
158. A. Sanbe, T. Daicho, R. Mizutani, T. Endo, N. Miyauchi, and J. Yamauchi Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy PLoS One 4 2009 e5351
159. H. Zheng, M. Tang, Q. Zheng, A.R. Kumarapeli, K.M. Horak, and Z. Tian Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy J Am Coll Cardiol 56 2010 1418 1426
160. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
161. C. Depre, Q. Wang, L. Yan, N. Hedhli, P. Peter, and L. Chen Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy Circulation 114 2006 1821 1828 (Pubitemid 44673357)
162. W.E. Stansfield, R.H. Tang, N.C. Moss, A.S. Baldwin, M.S. Willis, and C.H. Selzman Proteasome inhibition promotes regression of left ventricular hypertrophy Am J Physiol Heart Circ Physiol 294 2008 H645 H650
163. S. Meiners, H. Dreger, M. Fechner, S. Bieler, W. Rother, and C. Gunther Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system Hypertension 51 2008 302 308 (Pubitemid 351159943)
164. N. Hedhli, P. Lizano, C. Hong, L.F. Fritzky, S.K. Dhar, and H. Liu Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload Am J Physiol Heart Circ Physiol 295 2008 H1385 H1393
165. N. Hedhli, L. Wang, Q. Wang, E. Rashed, Y. Tian, and X. Sui Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22 Cardiovasc Res 77 2008 497 505 (Pubitemid 351197656)
166. M.L. Urso, P.M. Clarkson, D. Hittel, E.P. Hoffman, and P.D. Thompson Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins Arterioscler Thromb Vasc Biol 25 2005 2560 2566 (Pubitemid 43732279)
167. M.B. Reid Response of the ubiquitin-proteasome pathway to changes in muscle activity Am J Physiol Regul Integr Comp Physiol 288 2005 R1423 R1431
168. A. Nedergaard, K. Vissing, K. Overgaard, M. Kjaer, and P. Schjerling Expression patterns of atrogenic and ubiquitin proteasome component genes with exercise: effect of different loading patterns and repeated exercise bouts J Appl Physiol 103 2007 1513 1522 (Pubitemid 350033833)
169. A.J. Murton, D. Constantin, and P.L. Greenhaff The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy Biochim Biophys Acta 1782 2008 730 743
170. V. Adams, A. Linke, S. Gielen, S. Erbs, R. Hambrecht, and G. Schuler Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training Eur J Cardiovasc Prev Rehabil 15 2008 293 299
171. S. Usui, Y. Maejima, J. Pain, C. Hong, J. Cho, and J.Y. Park Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB Circ Res 109 2011 161 171
172. S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, and V. Polyakova Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991 (Pubitemid 36258721)
173. J. Weekes, K. Morrison, A. Mullen, R. Wait, P. Barton, and M.J. Dunn Hyperubiquitination of proteins in dilated cardiomyopathy Proteomics 3 2003 208 216 (Pubitemid 36254603)
174. J.M. Predmore, P. Wang, F. Davis, S. Bartolone, M.V. Westfall, and D.B. Dyke Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies Circulation 21 2010 997 1004
175. J. Wohlschlaeger, S.U. Sixt, T. Stoeppler, K.J. Schmitz, B. Levkau, and K. Tsagakis Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium J Heart Lung Transplant 29 2010 125 132
176. C. Kassiotis, K. Ballal, K. Wellnitz, D. Vela, M. Gong, and R. Salazar Markers of autophagy are downregulated in failing human heart after mechanical unloading Circulation 120 2009 S191 S197
177. Q. Zheng, H. Su, Z. Tian, and X. Wang Proteasome malfunction activates macroautophagy in the heart Am J Cardiovasc Dis 1 2011 214 226
178. A. Voigt, K. Bartel, K. Egerer, C. Trimpert, E. Feist, and C. Gericke Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy Basic Res Cardiol 105 2010 9 18
179. K. Otsuka, F. Terasaki, H. Shimomura, B. Tsukada, T. Horii, and T. Isomura Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress Heart Vessels 25 2010 474 484
180. T. Hayashi, K. Takada, and M. Matsuda Post-transient ischemia increase in ubiquitin conjugates in the early reperfusion Neuroreport 3 1992 519 520
181. T. Kamikubo, and T. Hayashi Changes in proteasome activity following transient ischemia Neurochem Int 28 1996 209 212 (Pubitemid 26004423)
182. J.N. Keller, F.F. Huang, H. Zhu, J. Yu, Y.S. Ho, and T.S. Kindy Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury J Cereb Blood Flow Metab 20 2000 1467 1473
183. A. Asai, N. Tanahashi, J.H. Qiu, N. Saito, S. Chi, and N. Kawahara Selective proteasomal dysfunction in the hippocampal CA1 region after transient forebrain ischemia J Cereb Blood Flow Metab 22 2002 705 710 (Pubitemid 34596463)
184. A.L. Bulteau, K.C. Lundberg, K.M. Humphries, H.A. Sadek, P.A. Szweda, and B. Friguet Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion J Biol Chem 276 2001 30057 30063
185. S.R. Powell, P. Wang, H.L. Katzeff, R. Shringarpure, C. Teoh, and I. Khaliulin Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function. Essential role of the proteasome Antioxid Redox Signal 7 2005 538 546 (Pubitemid 40563194)
186. S.R. Powell, K.J.A. Davies, and A. Divald Optimal determination of heart tissue 26S Proteasome activity requires maximal stimulating concentrations of ATP J Mol Cell Cardiol 42 2007 265 269 (Pubitemid 44970471)
187. N. Gurusamy, S. Goswami, G. Malik, and D.K. Das Oxidative injury induces selective rather than global inhibition of proteasomal activity J Mol Cell Cardiol 44 2008 419 428
188. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol Rev 82 2002 373 428 (Pubitemid 34654457)
189. A.A. Horwitz, A. Navon, M. Groll, D.M. Smith, C. Reis, and A.L. Goldberg ATP-induced structural transitions in PAN, the proteasome-regulatory ATPase complex in Archaea J Biol Chem 282 2007 22921 22929 (Pubitemid 47267319)
190. H. Huang, X. Zhang, S. Li, N. Liu, W. Lian, and E. McDowell Physiological levels of ATP negatively regulate proteasome function Cell Res 20 2010 1372 1385
191. R.B. Jennings, and C. Steenbergen Jr. Nucleotide metabolism and cellular damage in myocardial ischemia Annu Rev Physiol 47 1985 727 749 (Pubitemid 15142408)
192. M. Asai, O. Tsukamoto, T. Minamino, H. Asanuma, M. Fujita, and Y. Asano PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts J Mol Cell Cardiol 46 2009 452 462
193. E.N. Churchill, J.C. Ferreira, P.C. Brum, L.I. Szweda, and D. Mochly-Rosen Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion Cardiovasc Res 85 2010 385 394
194. M. Canton, I. Neverova, R. Menabo, J. Van Eyk, and F. Di Lisa Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts Am J Physiol Heart Circ Physiol 286 2004 H870 H877
195. I. Khaliulin, H. Schwalb, P. Wang, E. Houminer, L. Grinberg, and H. Katzeff Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins Free Radic Biol Med 37 2004 1 9 (Pubitemid 38746646)
196. Y. Park, S. Kanekal, and J.P. Kehrer Oxidative changes in hypoxic rat heart tissue Am J Physiol Heart Circ Physiol 260 1991 H1395 H1405
197. S.R. Powell, E.M. Gurzenda, and S.E. Wahezi Actin is oxidized during myocardial ischemia Free Radic Biol Med 30 2001 1171 1176 (Pubitemid 32441843)
198. K.J. Davies, S.W. Lin, and R.E. Pacifici Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein J Biol Chem 262 1987 9914 9920
199. K.J. Davies, and M.E. Delsignore Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure J Biol Chem 262 1987 9908 9913
200. M. Amici, G. Lupidi, M. Angeletti, E. Fioretti, and A.M. Eleuteri Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems Free Radic Biol Med 34 2003 987 996 (Pubitemid 36398558)
201. N.A. Osna, J. Haorah, V.M. Krutik, and T.M. Donohue Jr. Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo Hepatology 40 2004 574 582 (Pubitemid 39265578)
202. T. Reinheckel, N. Sitte, O. Ullrich, U. Kuckelkorn, K.J. Davies, and T. Grune Comparative resistance of the 20S and 26S proteasome to oxidative stress Biochem J 335 1998 637 642
203. B. Friguet, and L.I. Szweda Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein FEBS Lett 405 1997 21 25 (Pubitemid 27130365)
204. K. Okada, C. Wangpoengtrakul, T. Osawa, S. Toyokuni, K. Tanaka, and K. Uchida 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules J Biol Chem 274 1999 23787 23793
205. T. Reinheckel, O. Ullrich, N. Sitte, and T. Grune Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress Arch Biochem Biophys 377 2000 65 68 (Pubitemid 30257287)
206. T. Ishii, T. Sakurai, H. Usami, and K. Uchida Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 s proteasome Biochemistry 44 2005 13893 13901 (Pubitemid 41507469)
207. A. Divald, S. Kivity, P. Wang, E. Hochhauser, B. Roberts, and S. Teichberg Myocardial ischemic preconditioning preserves postischemic function of the 26S proteasome through diminished oxidative damage to 19S regulatory particle subunits Circ Res 106 2010 1829 1838
208. A.M. Pickering, A.L. Koop, C.Y. Teoh, G. Ermak, T. Grune, and K.J. Davies The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes Biochem J 432 2010 585 594
209. A. Divald, and S.R. Powell Proteasome mediates removal of proteins oxidized during myocardial ischemia Free Radic Biol Med 40 2006 156 164 (Pubitemid 41759413)
210. • OH formation in isolated ischemic rat hearts Free Radic Biol Med 9 1990 133 141
211. S.R. Powell, S.M. Samuel, P. Wang, A. Divald, M. Thirunavukkarasu, and S. Koneru Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia J Mol Cell Cardiol 44 2008 618 621
212. S.R. Powell, and A. Divald The ubiquitin-proteasome system in myocardial ischaemia and preconditioning Cardiovasc Res 85 2010 303 311
213. C.E. Murry, R.B. Jennings, and K.A. Reimer New insights into potential mechanisms of ischemic preconditioning Circulation 84 1991 442 445
214. + channels and myocardial preconditioning Circ Res 84 1999 973 979 (Pubitemid 29227676)
215. P. Korge, H.M. Honda, and J.N. Weiss Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning Proc Natl Acad Sci USA 99 2002 3312 3317 (Pubitemid 34240628)
216. R. Meller, J.A. Cameron, D.J. Torrey, C.E. Clayton, A.N. Ordonez, and D.C. Henshall Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons J Biol Chem 281 2006 7429 7436 (Pubitemid 43847514)
217. J.M. Pradillo, C. Romera, O. Hurtado, A. Cardenas, M.A. Moro, and J.C. Leza TNFR1 upregulation mediates tolerance after brain ischemic preconditioning J Cereb Blood Flow Metab 25 2005 193 203 (Pubitemid 40171201)
218. C. Liu, S. Chen, F. Kamme, and B.R. Hu Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia Neuroscience 134 2005 69 80 (Pubitemid 40943635)
219. T. Sato, N. Sasaki, B. O'Rourke, and E. Marban Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels J Am Coll Cardiol 35 2000 514 518 (Pubitemid 30125546)
220. K. Inagaki, L. Chen, F. Ikeno, F.H. Lee, K. Imahashi, and D.M. Bouley Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo Circulation 108 2003 2304 2307 (Pubitemid 37413533)
221. C.P. Baines, C.X. Song, Y.T. Zheng, G.W. Wang, J. Zhang, and O.L. Wang Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria Circ Res 92 2003 873 880 (Pubitemid 36542528)
222. Z. Cai, and G.L. Semenza PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning Circ Res 97 2005 1351 1359
223. Z. Cai, Z. Shen, L.V. Kaer, and L.C. Becker Ischemic preconditioning- induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency FASEB J 22 2008 4248 4257
224. T.G. Gillette, B. Kumar, D. Thompson, C.A. Slaughter, and G.N. DeMartino Differential role of the C-termini of AAA subunits of PA700 (19S regulator) in asymmetric assembly and activation of the 26S proteasome J Biol Chem 283 2008 31813 31822
225. G.N. DeMartino Purification of PA700, the 19S regulatory complex of the 26S proteasome Methods Enzymol 398 2005 295 306
226. X. Yu, and D.C. Kem Proteasome inhibition during myocardial infarction Cardiovasc Res 85 2010 312 320
227. S.R. Powell Proteasome inhibitors in myocardial ischemia, some concerns Ann Thorac Surg 85 2008 1503 1504 (Pubitemid 351381651)
228. J. Voortman, and G. Giaccone Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report BMC Cancer 6 2006 129
229. O. Enrico, B. Gabriele, C. Nadia, G. Sara, V. Daniele, and C. Giulia Unexpected cardiotoxicity in haematological bortezomib treated patients Br J Haematol 138 2007 396 397 (Pubitemid 47035391)
230. A. Hacihanefioglu, P. Tarkun, and E. Gonullu Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib Int J Hematol 88 2008 219 222
231. T. Muchamuel, M. Basler, M.A. Aujay, E. Suzuki, K.W. Kalim, and C. Lauer A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis Nat Med 15 2009 781 787